Literature DB >> 324574

Immune complexes in Behçet's syndrome and recurrent oral ulceration.

B D Williams, T Lehner.   

Abstract

Seventeen patients with Behçet's syndrome, 11 with recurrent oral ulceration, and eight controls were studied in an investigation of the part possibly played by immune complexes in the transition from focal oral ulceration to the multifocal syndrome. Changes in the distribution of C3 within the first peak of Sephadex G200 fractionated plasma were found in nine of the 17 patients with Behçet's syndrome (55%), three of the 11 patients with recurrent oral ulcers, and none of eight controls. These findings provide indirect evidence that immune complexes are found in the plasma of these patients. Immune complexes were more common in patients with the neuro-ocular type of Behçet's syndrome than in those with the mucocutaneous type, and in those with herpetiform ulcers than in those with major or minor aphthous ulcers. Immune complexes were also associated with active disease. These findings support the hypothesis that the formation of immune complexes is an important step in the pathogenesis of Behçet's syndrome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324574      PMCID: PMC1606934          DOI: 10.1136/bmj.1.6073.1387

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  Autoimmunity in oral diseases, with special reference to recurrent oral ulceration.

Authors:  T Lehner
Journal:  Proc R Soc Med       Date:  1968-05

2.  Acute phase proteins and C9 in patients with Behcet's syndrome and aphthous ulcers.

Authors:  M Adinolfi; T Lehner
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

3.  Determination of serum C9 level by immunodiffusion. Elevation in patients with infectious or allergic skin diseases.

Authors:  S Kawachi-Takahashi; K Tanaka; M Takahashi; T Kawashima; K Shimada
Journal:  Int Arch Allergy Appl Immunol       Date:  1975
  3 in total
  32 in total

1.  Cryoglobulins in Behçet's syndrome and recurrent oral ulceration: assay by laser nephelometry.

Authors:  T Lehner; A Losito; D G Williams
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

2.  Immunohistology of oral lesions from patients with recurrent oral ulcers and Behçet's syndrome.

Authors:  L W Poulter; T Lehner
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Behçet's disease: activated T lymphocytes in retinal perivasculitis.

Authors:  D G Charteris; C Champ; A R Rosenthal; S L Lightman
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

4.  Immune complex vasculitis in a patient with Behçet's syndrome.

Authors:  W Maciejewski; H J Bandmann
Journal:  Arch Dermatol Res       Date:  1979-03-31       Impact factor: 3.017

5.  Release of prostaglandins in experimental immunecomplex endophthalmitis and phacoallergic uveitis.

Authors:  A Rhi; P Bhattacherjee; R Misra
Journal:  Br J Ophthalmol       Date:  1978-02       Impact factor: 4.638

6.  A defect in immunoregulatory synovial fluid T cells in Behçet's syndrome.

Authors:  J Alcocer-Varela; A Laffon; C Abud-Mendoza; D Alarcon-Segovia
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

7.  Fibronectin and circulating immune complexes in Behet's disease.

Authors:  K Ozoran; N Düzgün; H Tutkak; A Gürler; G Tokgöz
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

8.  Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Behçet's disease.

Authors:  Travis Hughes; Filiz Ture-Ozdemir; Fatma Alibaz-Oner; Patrick Coit; Haner Direskeneli; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

9.  Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.

Authors:  G Valesini; M Picardo; R Pastore; P Pivetti; U Serafini
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

10.  Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.

Authors:  M L Pacor; D Biasi; C Lunardi; P Cortina; P Caramaschi; D Girelli; M Botto; G Urbani; G Lombardo; L M Bambara
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.